expert report on neoadjuvant immune checkpoint inhibitors for melanoma
Published 1 year ago • 648 plays • Length 4:58Download video MP4
Download video MP3
Similar videos
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
6:52
expert report on novel data in (neo)adjuvant treatment of melanoma from asco 2022
-
4:31
expert report on treatment with tumour-infiltrating lymphocytes (tils)
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
7:25
how to manage toxicities from immune checkpoint inhibitors?
-
3:40
aacr 2023 highlights on advances in the treatment of resected high-risk melanoma with jeffrey weber
-
2:22
#esmo22 highlights on neoadj. vs adjuvant pembrolizumab in resected stage iii-iv melanoma:swog s1801
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
8:20
kanser hastaları i̇çin tavsiyeler ve yasaklar | prof. saraçoğlu
-
55:18
lecture on cancer [ coffee/ cancer; ev pembro; censoring] to ucsf fresno
-
8:34
#esmo21 expert video report on melanoma
-
6:49
expert video report on advances in melanoma clinical research from aacr annual meeting 2021
-
4:44
expert report on survival data from pivotal trials with parp inhibitors for brca-mut. ovarian cancer
-
2:17
#esmo22 highlights on pembrolizumab with crt in locally advanced hnscc: the keynote-412 study
-
6:02
esmo expert video report on current issues in immuno-oncology
-
3:16
#esmo22 highlights on tils versus ipilimumab in patients with advanced melanoma: the phase 3 study
-
2:46
#esmo22 highlights on neoadjuvant ici in locally advanced dmmr colon cancer: the niche-2 study
-
3:11
esmo 2020 highlights on pembrolizumab in la-hnscc: the gortec 2015-01 “pembrorad” study